It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2016-2017. During the financial year, The Company’s consolidated revenues were at Rs. 140.8 billion, which was less by almost 9% compared to the previous year. EBITDA was at Rs. 25.5 billion versus Rs. 36.3 billion in FY2016, and accounted for 18.1% of consolidated revenues. Profit before tax (PBT) was at Rs. 14.7 billion compared to Rs. 27.1 billion in the previous year. Profit after tax (PAT) was at Rs. 12 billion or 8.5% of revenues. It was 40% less than FY2016.
The Board of directors of the company has proposed a dividend of Rs. 20/- per share on equity shares of Rs. 5/-.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
